ArcticZymes Technologies ASA
B4V
Company Profile
Business description
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.
Contact
Sykehusveien 23
Tromso9294
NORT: +47 77648900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
53
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,008.30 | 13.60 | -0.17% |
| CAC 40 | 7,285.86 | 44.11 | -0.60% |
| DAX 40 | 21,205.86 | 105.16 | -0.49% |
| Dow JONES (US) | 38,170.41 | 971.82 | -2.48% |
| FTSE 100 | 8,275.66 | 0.06 | 0.00% |
| HKSE | 21,493.25 | 98.11 | 0.46% |
| NASDAQ | 15,870.90 | 415.55 | -2.55% |
| Nikkei 225 | 34,218.06 | 61.86 | -0.18% |
| NZX 50 Index | 11,836.69 | 282.30 | -2.33% |
| S&P 500 | 5,158.20 | 124.50 | -2.36% |
| S&P/ASX 200 | 7,811.50 | 7.60 | -0.10% |
| SSE Composite Index | 3,305.62 | 14.19 | 0.43% |